Christopher Heery

CIK 1789632 · View on SEC EDGAR ↗

Insider

First SEC filing: Oct. 8, 2019 · Latest: Oct. 8, 2019

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

1 other filing hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 19, 2019 DTIL P 2,235 $12.08 $26,999 2,485 Direct +894.00% Acquired -97.6% (price as of 2026-08-19)
Dec. 19, 2019 DTIL P 250 $12.09 $3,022 250 Direct Acquired -97.6% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 8, 2020 DTIL Employee Stock Option (Right to Buy) Common Stock (133,206) $8.21 June 7, 2030 133,206 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Oct. 8, 2019 DTIL Employee Stock Option (Right to Buy)→ Common Stock (200,000) 200,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DTIL

M.D. Chief Medical Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2020 $430,000 $146,200 $726,001 $11,179 $1,313,380
2019 $286,667 $150,534 $1,737,812 $6,832 $2,181,845

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.